| Value | ₹67.94 Cr |
|---|
BSE filing, BSE: 544657. Summary written from the filing by ALFA Finder's alert engine.
Pajson Agro India Ltd: key numbers
- Share price
- ₹329.45
- Market cap
- ₹784.4 Cr
- Revenue (annual)
- ₹255.7 Cr
- Net profit (annual)
- ₹24.78 Cr
- P/E (TTM)
- 31.6×Sector 46.8×
- Promoter holding
- 62.47%
- FII holding
- 0.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pajson Agro India Ltd
All →Pajson Agro India Annual General Meeting
Pajson Agro India will hold its 2nd EGM on December 4, 2026 to approve the Employee Stock Option Scheme 2026 and grants to group-company employees. The ESOP covers up to 11,90,480 options with no stated monetary value.
Pajson Agro India Earnings Call Transcript: Key Takeaways
H1 FY27 total income +23% YoY to ~₹145 Cr; EBITDA ~₹20 Cr (14%); PAT ~₹12.6 Cr. Management concedes forex and freight margin compression; Vijayanagram delayed by cyclones.
Pajson Agro India Investor Presentation: Key Takeaways
H1 FY27 revenue ₹143.39 Cr (+21.1% YoY), PAT ₹12.56 Cr (-11.6% YoY), EBITDA margin 14.0%. Pending all-share Pacific Global FZCO acquisition.
Pajson Agro India Fund Raise of ₹354.5 Cr
Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.
- Value
- ₹354.5 Cr
Pajson Agro India Acquisition Worth ₹354.5 Cr
Pajson Agro's board approved acquiring 100% of Pacific Global FZCO for Rs 354.52 Crore via share swap. A preferential issue and EGM on December 4 follow.
- Value
- ₹354.5 Cr
Pajson Agro India Results Update
Pajson Agro India Limited reported H1 FY27 total income of ₹145.11 crore with 23% YoY growth. The company is tripling capacity with a 35,000 MTPA greenfield facility.
- processing capacity
- 35000.0 MTPA
Other business update announcements
All →Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Rajshree Sugars & Chemicals Business Update
Rajshree Sugars reported October 2026 operational data for its three sugar units. Sugar sales were 17,849 MT, with no cane crushed during the month.
Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr